⌕
Jazz Pharmaceuticals · JAZZ · Nasdaq
Tenet 47 · Mixed
Compare
$240.71+0.39%At closeTenet 47 · Mixed
$240.71+0.94 (+0.39%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Jazz Pharmaceuticals (JAZZ) Institutional Ownership

13F filers reported holding 51.7% of Jazz Pharmaceuticals (JAZZ) shares as of Sep 30, 2026, across 463 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
51.7%
Sep 30, 2026
13F filers
463
quarter ended Sep 30, 2026
13F value
$7.7B
33.2M shares
Quarter's fund flow
Mild accumulation
78 new · 43 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (78 new · 185 increased · 134 reduced · 43 closed · 23 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 463 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 6, 2026COZADD BRUCE CdirectorAcquired · Option exercise734$136.18↗
Nov 6, 2026COZADD BRUCE CdirectorAcquired · Option exercise85,766$136.18↗
Nov 6, 2026COZADD BRUCE CdirectorDisposed · Open-market sale27,714$234.91↗
Nov 6, 2026COZADD BRUCE CdirectorDisposed · Open-market sale10,688$235.82↗
Nov 6, 2026COZADD BRUCE CdirectorDisposed · Open-market sale24,483$236.84↗
Nov 6, 2026COZADD BRUCE CdirectorDisposed · Open-market sale5,923$237.39↗
Nov 6, 2026COZADD BRUCE CdirectorDisposed · Option exercise734Incentive Stock Option (right to buy)—↗
Nov 6, 2026COZADD BRUCE CdirectorDisposed · Option exercise85,766Non-Qualified Stock Option (right to buy)—↗
Nov 4, 2026Carr PatriciaSVP, Chief Accounting OfficerAcquired · Option exercise1,250$140.03↗
Nov 4, 2026Carr PatriciaSVP, Chief Accounting OfficerDisposed · Open-market sale1,250$231.37↗
Nov 4, 2026Carr PatriciaSVP, Chief Accounting OfficerDisposed · Open-market sale163$231.27↗
Nov 4, 2026Carr PatriciaSVP, Chief Accounting OfficerDisposed · Option exercise1,250Non-Qualified Stock Option (right to buy)—↗
Nov 3, 2026GALA RENEE DPresident & CEODisposed · Open-market sale1,000$225.37↗
Nov 2, 2026COZADD BRUCE CdirectorDisposed · Open-market sale6,000$215.84↗
Oct 6, 2026GALA RENEE DPresident & CEODisposed · Open-market sale2,000$236.40↗
Oct 1, 2026COZADD BRUCE CdirectorDisposed · Open-market sale6,000$230.33↗
Sep 10, 2026Patil Neena MEVP & Chief Legal OfficerDisposed · Open-market sale1,200$240.94↗
Sep 8, 2026Henderson Mary ElizabethSVP, Technical OperationsDisposed · Tax withholding1,412$243.03↗
Sep 8, 2026Henderson Mary ElizabethSVP, Technical OperationsDisposed · Tax withholding15$241.20↗
Sep 8, 2026GALA RENEE DPresident & CEODisposed · Tax withholding1,967$246.81↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Jazz Pharmaceuticals do institutions hold?

13F filers reported holding 51.7% of Jazz Pharmaceuticals' shares as of Sep 30, 2026, across 463 filers.

How many 13F filers hold Jazz Pharmaceuticals?

Jazz Pharmaceuticals was held by 463 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.